Hubei jinjian biology co., LTD.

Hubei Jinjian biology is a biotechnology company mainly engaged in the research and development, production and sales of in vitro diagnostic reagents. The company was established in September 2019. Its R & D center is located in China Optics Valley 58 maker Industrial Park, and its production base is located at No. 38, Qigu Avenue, new Yangtze River Industrial Park, Xianning, Hubei Province. It has a clean workshop with an area of 1200 square meters and a production capacity of 150 million people As a member of China Chamber of Commerce for the import and export of pharmaceutical and health products, R & D and production management are operated in strict accordance with the international quality management system to ensure the high quality of products and the accuracy of customer testing. Relying on the talent and technology advantages of Wuhan and Xianning, Jinjian biology has formed a complete industrialization system of R & D, production and sales in the field of biological diagnosis, providing a strong engine power for the sustainable development of the company. Jinjian's R & D and production technology team is a young, efficient and hardworking technical team. The R & D department has submitted 4 invention patents related to diagnostic reagents this year, and 10 utility models have been submitted to the Patent Office for examination and approval. At present, the research and development team has 21 people, including 2 doctors (10%), 12 Masters (57%) and 7 undergraduates (33%). Among them, 4 have more than 15-20 years' experience in R & D or production of external diagnostic reagents, and 10 have more than 10 years' experience in R & D or production of external diagnostic reagents, which provides a strong human resource guarantee for the continuous introduction of new products by Jinjian bio. Jinjian bio focuses on high-tech products to serve customers. The company has three major IVD technology platforms: colloidal gold qualitative platform, quantitative platform, fluorescence chromatography quantitative platform and magnetic particle chemiluminescence platform. It integrates Biotechnology (BT) and electronic information technology (it), and is committed to developing fast, accurate and convenient clinical detection products for disease diagnosis, and striving to provide convenience for users Rich bedside diagnostic products (POCT). The company has successfully developed colloidal gold quantitative analyzer, fluorescence chromatography analyzer, magnetic particle chemiluminescence analyzer and other detection equipment. A novel coronavirus IgM/IgG antibody (colloidal gold) combined detection reagent with excellent quality has been successfully developed and quickly entered the white list of China health care products import and export chamber to contribute to the global fight against disease. The company has independently developed more than 100 diagnostic products including inflammatory indicators, myocardial infarction, gastrointestinal tract, kidney disease, hepatobiliary, pancreatic related diseases, infectious diseases, drug abuse (drug detection), food safety and other diagnostic products in colloidal gold, fluorescence chromatography quantitative, magnetic particle chemiluminescence platform. Jinjian bio adheres to the principle of "quality first, user first", explores our diagnosis and detection solutions, and makes a contribution to human health and better life!